OVOS1 (AA 57-87), (N-Term) Antikörper
Kurzübersicht für OVOS1 (AA 57-87), (N-Term) Antikörper (ABIN953958)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 57-87, N-Term
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 57-87 amino acids from the N-terminal region of human OVOS.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- OVOS1
-
Andere Bezeichnung
- OVOS
-
Hintergrund
- OVOS is able to inhibit all four classes of proteinases by a unique 'trapping' mechanism (By similarity).Synonyms: 2, Ovostatin homolog 2
-
Molekulargewicht
- 161251 Da
-
Gen-ID
- 9606
Target
-